US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P SmallCap Health Care ETF

55.58

-0.1250-0.22%

Volume:2K

Turnover:94.94K

Market Cap:190.07M

PE:- -

High:55.60

Open:55.51

Low:55.48

Close:55.70

52wk High:56.45

52wk Low:39.08

Shares:3.42M

Float Shares:3.42M

Volume Ratio:0.21

T/O Rate:0.05%

Dividend:0.00

Dividend Rate:0.01%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Molina Healthcare: FY Guidance Also Includes Loss of $1.00 Per Share Due to Performance of Traditional Mapd Product

THOMSON REUTERS

Molina Healthcare Inc Outlook Full Year 2026 Adjusted Earnings to at Least $5.25 Per Diluted Share

THOMSON REUTERS

Molina Healthcare - Fy2026 Premium Revenue Guidance Unchanged at Approx $42 Bln

THOMSON REUTERS

Molina Healthcare: FY Guidance Includes Loss of $1.50 Per Share Due to Implementation of New Florida Medicaid Contract in Q4

THOMSON REUTERS

Molina Healthcare Inc: Medicaid Mcr for Q2 of 2026 was 92.7%

THOMSON REUTERS

Molina Healthcare - Q2 2026 Premium Revenue About $10.20 Bln

THOMSON REUTERS

Molina Healthcare Q2 Premium Revenue USD 10,244 Million

THOMSON REUTERS

Molina Healthcare Q2 EPS USD 1.19

THOMSON REUTERS

Corcept Therapeutics Schedules Second-quarter Results Conference Call

Why Molina Healthcare (MOH) Is Down 6.2% After S&P Index Shift And Rising Profit Concerns

Simply Wall St.

This Medicaid Insurer's Stock Has Climbed in 2026. Investors Still Have Doubts.

Is Krystal Biotech (KRYS) Overvalued On Its KB801 Patent Data Update?

Simply Wall St.

Krystal Biotech - Discontinues Clinical Study to Advance KB801 into Pivotal Trial; no Safety Concerns Observed - SEC Filing

THOMSON REUTERS

Krystal Biotech - no Further Subject-level Updates from Discontinued Study; Pivotal Trial Results Expected in Due Course - SEC Filing

THOMSON REUTERS

Krystal Biotech - Files Response with Uspto on KB801 Patent Application - SEC Filing

THOMSON REUTERS

Construction Firm Tutor Perini Jumps on S&P Smallcap Inclusion

Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34

THOMSON REUTERS

AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.

Tutor Perini Set to Join the S&P SmallCap 600 Index

MT Newswires Live

Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PSCH/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PSCH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","market":"US","secType":"STK","nameCN":"Invesco S&P SmallCap Health Care ETF","latestPrice":55.575,"timestamp":1787760308870,"preClose":55.7,"halted":0,"volume":1709,"delay":0,"changeRate":-0.002244165170556553,"floatShares":3420000,"shares":3420000,"eps":0,"marketStatus":"Trading","change":-0.125,"latestTime":"08-26 12:05:52 EDT","open":55.5076,"high":55.6,"low":55.4825,"amount":94936.76153999999,"amplitude":0.00211,"askPrice":55.57,"askSize":200,"bidPrice":55.47,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787774400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":55.7,"sharesOutstanding":3220000,"nav":55.44727,"aum":189075190.7,"dividendRate":0.000054,"bidAskSpread":0.001784,"preHourTrading":{"tag":"盘前","latestPrice":54.57,"preClose":55.7,"latestTime":"07:00 EDT","volume":53,"amount":2892.21,"timestamp":1787742014879,"change":-1.13,"changeRate":-0.020287,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":55.7,"preClose":55.7,"latestTime":"19:30 EDT","volume":12,"amount":666.72,"timestamp":1787700602218,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.206979,"impliedVol":0.1092,"impliedVolPercentile":0.6733},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","floatShares":3420000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.206979,"shares":3420000,"dividePrice":0.003,"high":55.6,"amplitude":0.00211,"preClose":55.7,"low":55.4825,"week52Low":39.08,"pbRate":"--","week52High":56.454,"institutionHeld":0,"latestPrice":55.575,"committee":0.2,"eps":0,"divideRate":0.000054,"volume":1709,"delay":0,"ttmEps":0,"open":55.5076,"prevYearClose":44.0553,"prevWeekClose":55.6522,"prevMonthClose":53.39,"prevQuarterClose":52.3666,"fiveDayClose":56.22,"twentyDayClose":53.2244,"sixtyDayClose":44.8324},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSCH\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"PSCH","amount":0.00033,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-09-22","symbol":"PSCH","amount":0.00259,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PSCH","amount":0.00199,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-24","symbol":"PSCH","amount":0.01419,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSCH","amount":0.01801,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSCH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.01949,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00522,"currency":"USD"},{"executeDate":"2022-03-31","recordDate":null,"paymentDate":"2022-03-31","value":3,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.00448,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.03613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSCH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSCH\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653936177","title":"Molina Healthcare: FY Guidance Also Includes Loss of $1.00 Per Share Due to Performance of Traditional Mapd Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2653936177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653936177?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:15","pubTimestamp":1784751301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nPLX06MQD7:10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4585","PSCH","MOH","SG9999014039.USD","BK4588","BK4154","SG9999014013.SGD","SG9999014021.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653933087","title":"Molina Healthcare Inc Outlook Full Year 2026 Adjusted Earnings to at Least $5.25 Per Diluted Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2653933087","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653933087?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:15","pubTimestamp":1784751301,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nPLX06MQD7:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999014013.SGD","SG9999014021.USD","SG9999014039.USD","BK4154","BK4532","SG9999014005.SGD","PSCH","BK4585","MOH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653793548","title":"Molina Healthcare - Fy2026 Premium Revenue Guidance Unchanged at Approx $42 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2653793548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653793548?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:15","pubTimestamp":1784751301,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nPLX06MQD7:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","SG9999014021.USD","BK4588","BK4532","BK4154","SG9999014013.SGD","SG9999014039.USD","PSCH","SG9999014005.SGD","MOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653793544","title":"Molina Healthcare: FY Guidance Includes Loss of $1.50 Per Share Due to Implementation of New Florida Medicaid Contract in Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2653793544","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653793544?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:15","pubTimestamp":1784751301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nPLX06MQD7:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","SG9999014021.USD","PSCH","SG9999014013.SGD","BK4588","BK4585","MOH","SG9999014039.USD","SG9999014005.SGD","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653793543","title":"Molina Healthcare Inc: Medicaid Mcr for Q2 of 2026 was 92.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653793543","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653793543?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:15","pubTimestamp":1784751301,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nPLX06MQD7:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","PSCH","BK4588","SG9999014039.USD","SG9999014013.SGD","BK4585","SG9999014005.SGD","SG9999014021.USD","BK4154","MOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653793324","title":"Molina Healthcare - Q2 2026 Premium Revenue About $10.20 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2653793324","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653793324?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:15","pubTimestamp":1784751301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nPLX06MQD7:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","SG9999014021.USD","PSCH","SG9999014013.SGD","BK4588","BK4585","MOH","SG9999014039.USD","SG9999014005.SGD","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653339793","title":"Molina Healthcare Q2 Premium Revenue USD 10,244 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2653339793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653339793?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:15","pubTimestamp":1784751301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nPLX06MQD7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MOH","BK4154","BK4532","SG9999014005.SGD","SG9999014021.USD","BK4585","PSCH","SG9999014013.SGD","BK4588","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653314793","title":"Molina Healthcare Q2 EPS USD 1.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2653314793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653314793?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:15","pubTimestamp":1784751301,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nPLX06MQD7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999014013.SGD","BK4588","MOH","PSCH","SG9999014021.USD","BK4154","SG9999014039.USD","SG9999014005.SGD","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653798193","title":"Corcept Therapeutics Schedules Second-quarter Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2653798193","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653798193?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:05","pubTimestamp":1784750729,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics schedules second-quarter results conference callCorcept set July 29, 2026 to report second-quarter financial results, issue a corporate update, host a conference call at 5 p.m. ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL1V8Pdx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","BK4532","CORT","LU0566484027.USD","PSCH","BK4007","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653750354","title":"Why Molina Healthcare (MOH) Is Down 6.2% After S&P Index Shift And Rising Profit Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2653750354","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653750354?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:19","pubTimestamp":1784719157,"startTime":"0","endTime":"0","summary":"On 16 July 2026, index provider S&P Dow Jones Indices moved Molina Healthcare (NYSE: MOH) from the S&P 600 to the larger-cap S&P 400, aligning it with the S&P 400 Health Care sector benchmark.\nAt the same time, analysts' expectations for a sharp year-over-year earnings and revenue decline have increased attention on Molina's medical cost trends and reimbursement outlook.\nNext, we will examine how the anticipated earnings deceleration and profitability pressure could reshape Molina...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-moh/molina-healthcare/news/why-molina-healthcare-moh-is-down-62-after-sp-index-shift-an","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-moh/molina-healthcare/news/why-molina-healthcare-moh-is-down-62-after-sp-index-shift-an","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DECU","BK4585","BK4581","BK4532","SG9999014021.USD","VOTE","LABU","RGLO","PSCH","BK4588","MOH.AU","PMDE","BK7104","SG9999014039.USD","BK4154","VGFPF","SG9999014013.SGD","FEBU","XBI","MOH","GXDW","XLV","JOYT","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653312237","title":"This Medicaid Insurer's Stock Has Climbed in 2026. Investors Still Have Doubts.","url":"https://stock-news.laohu8.com/highlight/detail?id=2653312237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653312237?lang=en_us&edition=fundamental","pubTime":"2026-07-22 14:00","pubTimestamp":1784700000,"startTime":"0","endTime":"0","summary":"Wall Street has grown more confident that insurers in the Medicare Advantage market for seniors are taming elevated medical spending. But when it comes to Medicaid, a joint federal and state program s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014021.USD","MOH","BK4585","SG9999014039.USD","SG9999014013.SGD","BK4532","BK4588","PSCH","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653735352","title":"Is Krystal Biotech (KRYS) Overvalued On Its KB801 Patent Data Update?","url":"https://stock-news.laohu8.com/highlight/detail?id=2653735352","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653735352?lang=en_us&edition=fundamental","pubTime":"2026-07-22 11:30","pubTimestamp":1784691056,"startTime":"0","endTime":"0","summary":"Why KB801’s Patent Filing Matters For Krystal Biotech Stock\nKrystal Biotech (KRYS) recently filed a response with the U.S. Patent and Trademark Office for KB801, sharing previously undisclosed single patient data on corneal defect closure from a discontinued neurotrophic keratitis study.\nThe company stressed that this observation comes from one patient and is not a substitute for clinical trial results. However, the disclosure offers investors a clearer view of how KB801 is progressing toward...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/is-krystal-biotech-krys-overvalued-on-its-kb801-patent-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/is-krystal-biotech-krys-overvalued-on-its-kb801-patent-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4139","HELX","XBI","BK4581","PSCH","KRYS","DCF","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653857567","title":"Krystal Biotech - Discontinues Clinical Study to Advance KB801 into Pivotal Trial; no Safety Concerns Observed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653857567","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653857567?lang=en_us&edition=fundamental","pubTime":"2026-07-22 05:25","pubTimestamp":1784669159,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N18X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HELX","KRYS","BK4139","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653785755","title":"Krystal Biotech - no Further Subject-level Updates from Discontinued Study; Pivotal Trial Results Expected in Due Course - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653785755","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653785755?lang=en_us&edition=fundamental","pubTime":"2026-07-22 05:25","pubTimestamp":1784669159,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N18X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRYS","PSCH","HELX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653734785","title":"Krystal Biotech - Files Response with Uspto on KB801 Patent Application - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653734785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653734785?lang=en_us&edition=fundamental","pubTime":"2026-07-22 05:25","pubTimestamp":1784669159,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N18X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PSCH","KRYS","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653158270","title":"Construction Firm Tutor Perini Jumps on S&P Smallcap Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2653158270","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653158270?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:57","pubTimestamp":1784638676,"startTime":"0","endTime":"0","summary":"BUZZ-Construction firm Tutor Perini jumps on S&P SmallCap inclusion** Infrastructure contractor Tutor Perini'sTPC.Nshares up 6.7% before the bell on Tues at $85.93 as co poised to join S&P SmallCap 600 index.SPCY** TPC to replace Krystal BiotechKRYS.Oin SPCY effective Fri, Jul 24, S&P Dow Jones Indices said late Mon** KRYS migrating to S&P MidCap 400 index.IDXto replace homebuilder Taylor MorrisonTMHC.N, which is beingacquiredby Berkshire HathawayBRKa.N** Shares of KRYS up 0.2% at $340.06 before the bell** Stephens analyst Melissa Roberts said in a note she expects passive funds will need to buy 6 mln TPC shares, which implies about 11 days of buying demand** Sylmar, California-based TPC has ~52.6 mln shares outstanding for $4.2 bln market cap** At Mon close, TPC stock up 20% YTD** All 5 brokerages covering the stock are bullish and their median PT is $118, per LSEG data","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL6N43N0NS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","LU2065169927.USD","TMHC","KRYS","LU2065171311.SGD","BK4088","TPC","LU2065170008.USD","LU2065171402.SGD","HELX","BK4139","BK4129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653277231","title":"Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277231","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277231?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:34","pubTimestamp":1784637260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0YI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","MEDX","IBRN","PSCH","FBT","BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653529241","title":"AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2653529241","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653529241?lang=en_us&edition=fundamental","pubTime":"2026-07-21 06:47","pubTimestamp":1784587635,"startTime":"0","endTime":"0","summary":"An announcement from AFT Pharmaceuticals Ltd. ( ($NZ:AFT) ) is now available. AFT Pharmaceuticals has received tentative U.S. FDA approval for Scom...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aft-pharmaceuticals-secures-tentative-fda-nod-for-scomara-eyes-growth-outside-u-s?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aft-pharmaceuticals-secures-tentative-fda-nod-for-scomara-eyes-growth-outside-u-s?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","TECB","PINK","GDOC","IBB","FRTY","MRNX","BMED","MRNY","BK4585","BK4588","IYH","AFT","BBP","LABU","IDNA","MEDI","RSPH","SYNB","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249554","title":"Tutor Perini Set to Join the S&P SmallCap 600 Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249554","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249554?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:44","pubTimestamp":1784583863,"startTime":"0","endTime":"0","summary":"Tutor Perini (TPC) will join the S&P SmallCap 600 index before market opens on July 24, the S&P Dow Jones Indices said in a late Monday statement.The company will replace Krystal Biotech (KRYS), which will join the S&P MidCap 400 index","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HELX","XSHQ","PSCH","LU2065171311.SGD","LU2065169927.USD","TPC","KRYS","BK4129","XJR","LU2065170008.USD","SBB","XSMO","SIXS","SDD","TPC.AU","LU2065171402.SGD","BK7136","QVMS","BK4139","SAA","RZV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249586","title":"Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249586","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249586?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:20","pubTimestamp":1784582423,"startTime":"0","endTime":"0","summary":"Berkshire Hathaway (BRK.B) (BRK.A) (BRK.A/BRK.B) is acquiring Taylor Morrison Home (TMHC) in a deal expected to close on or about that date, pendin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/krystal-biotech-to-replace-taylor-morrison-in-sp-400-at-open-on-7-24-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/krystal-biotech-to-replace-taylor-morrison-in-sp-400-at-open-on-7-24-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","HELX","PSCH","KRYS","TMHC","BK4088"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}